A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients

Clinical trial NCT02672540 · COMPLETED

Trial details

NCT number: NCT02672540
Sponsor: Prolong Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia, Sickle Cell

Start date: 2016-07-01
Primary completion: 2017-05-31
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.